enrolled

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Blockchain-Based App Wins UN Secretary-General’s Innovation & Sustainability Award

July 23, 2022, New York - The UN Joint Staff Pension Fund (UNJSPF) partnered with the UN International Computing Center (UNICC) to launch a Digital Certificate of Entitlement (DCE) app to modernize the tracking and eligibility of UN retirees. This app allows retirees to use their smartphone, tablet, or another personal device to submit an electronic certificate of eligibility instead of a paper-based submission. The DCE uses cutting-edge biometric/facial recognition, blockchain, and global positioning technologies to track the eligibility of retirees. The DCE project was piloted in 2020 with retirees